417 related articles for article (PubMed ID: 11838845)
1. Pulmonary hypertension in systemic lupus erythematosus: evaluation of clinical characteristics and response to immunosuppressive treatment.
Tanaka E; Harigai M; Tanaka M; Kawaguchi Y; Hara M; Kamatani N
J Rheumatol; 2002 Feb; 29(2):282-7. PubMed ID: 11838845
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases.
Jais X; Launay D; Yaici A; Le Pavec J; Tchérakian C; Sitbon O; Simonneau G; Humbert M
Arthritis Rheum; 2008 Feb; 58(2):521-31. PubMed ID: 18240255
[TBL] [Abstract][Full Text] [Related]
3. Protein-losing enteropathy in systemic lupus erythematosus: analysis of the clinical features of fifteen patients.
Zheng WJ; Tian XP; Li L; Jing HL; Li F; Zeng XF; Tang FL
J Clin Rheumatol; 2007 Dec; 13(6):313-6. PubMed ID: 18176138
[TBL] [Abstract][Full Text] [Related]
4. [Pulmonary hypertension associated with systemic lupus erythematosus].
Haas C
Bull Acad Natl Med; 2004; 188(6):985-97; discussion 997. PubMed ID: 15651427
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of antiphospholipid antibodies following cyclophosphamide therapy in patients with systemic lupus erythematosus.
Vlachoyiannopoulos PG; Toya SP; Katsifis G; Zintzaras E; Tzioufas AG; Moutsopoulos HM
J Rheumatol; 2008 Sep; 35(9):1768-75. PubMed ID: 18634157
[TBL] [Abstract][Full Text] [Related]
6. Sjogren's syndrome-onset lupus patients have distinctive clinical manifestations and benign prognosis: a case-control study.
Xu D; Tian X; Zhang W; Zhang X; Liu B; Zhang F
Lupus; 2010 Feb; 19(2):197-200. PubMed ID: 19900977
[TBL] [Abstract][Full Text] [Related]
7. [A case of systemic lupus erythematosus with pulmonary hypertension].
Nakano K; Tanaka Y; Aso M; Saito K; Fujii K; Takazawa A; Ota T
Ryumachi; 2000 Jun; 40(3):612-9. PubMed ID: 10920686
[TBL] [Abstract][Full Text] [Related]
8. Systemic lupus erythematosus in Thai children: clinicopathologic findings and outcome in 82 patients.
Pattaragarn A; Sumboonnanonda A; Parichatikanond P; Supavekin S; Suntornpoch V; Vongjirad A
J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S232-41. PubMed ID: 16856445
[TBL] [Abstract][Full Text] [Related]
9. Severe infections in plasmapheresis-treated systemic lupus erythematosus.
Aringer M; Smolen JS; Graninger WB
Arthritis Rheum; 1998 Mar; 41(3):414-20. PubMed ID: 9506568
[TBL] [Abstract][Full Text] [Related]
10. Herpes zoster in systemic lupus erythematosus.
Manzi S; Kuller LH; Kutzer J; Pazin GJ; Sinacore J; Medsger TA; Ramsey-Goldman R
J Rheumatol; 1995 Jul; 22(7):1254-8. PubMed ID: 7562754
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary arterial hypertension in systemic lupus erythematosus may benefit by addition of immunosuppression to vasodilator therapy: an observational study.
Kommireddy S; Bhyravavajhala S; Kurimeti K; Chennareddy S; Kanchinadham S; Rajendra Vara Prasad I; Rajasekhar L
Rheumatology (Oxford); 2015 Sep; 54(9):1673-9. PubMed ID: 25929760
[TBL] [Abstract][Full Text] [Related]
12. A comparison of thrombotic thrombocytopenic purpura in an inception cohort of patients with and without systemic lupus erythematosus.
Letchumanan P; Ng HJ; Lee LH; Thumboo J
Rheumatology (Oxford); 2009 Apr; 48(4):399-403. PubMed ID: 19202160
[TBL] [Abstract][Full Text] [Related]
13. Controversies and advances in the management of systemic lupus erythematosus in children and adolescents.
Tucker LB
Best Pract Res Clin Rheumatol; 2002 Jul; 16(3):471-80. PubMed ID: 12387811
[TBL] [Abstract][Full Text] [Related]
14. Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy.
Mok MY; Lo Y; Chan TM; Wong WS; Lau CS
J Rheumatol; 2005 Apr; 32(4):609-15. PubMed ID: 15801014
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary hypertension in systemic lupus erythematosus.
Gladman DD; Sternberg L
J Rheumatol; 1985 Apr; 12(2):365-7. PubMed ID: 4032410
[TBL] [Abstract][Full Text] [Related]
16. [Clinical course and prognosis in SLE patients with pulmonary hypertension: a comparative study with primary pulmonary hypertension].
Fusegawa S; Mikami T; Hashimoto M; Yamada Y; Kobayashi T; Yasuda H; Sagawa A; Fujisaku A
Kokyu To Junkan; 1991 Aug; 39(8):819-23. PubMed ID: 1925104
[TBL] [Abstract][Full Text] [Related]
17. Treatment of refractory SLE with rituximab plus cyclophosphamide: clinical effects, serological changes, and predictors of response.
Jónsdóttir T; Gunnarsson I; Risselada A; Henriksson EW; Klareskog L; van Vollenhoven RF
Ann Rheum Dis; 2008 Mar; 67(3):330-4. PubMed ID: 17827182
[TBL] [Abstract][Full Text] [Related]
18. Primary pulmonary hypertension in a patient with systemic lupus erythematosus: partial improvement with cyclophosphamide.
Groen H; Bootsma H; Postma DS; Kallenberg CG
J Rheumatol; 1993 Jun; 20(6):1055-7. PubMed ID: 8350313
[TBL] [Abstract][Full Text] [Related]
19. Diffuse alveolar hemorrhage in systemic lupus erythematosus: a retrospective study in China.
Shen M; Zeng X; Tian X; Zhang F; Zeng X; Zhang X; Xu W
Lupus; 2010 Oct; 19(11):1326-30. PubMed ID: 20647253
[TBL] [Abstract][Full Text] [Related]
20. Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis.
Gunnarsson I; Sundelin B; Jónsdóttir T; Jacobson SH; Henriksson EW; van Vollenhoven RF
Arthritis Rheum; 2007 Apr; 56(4):1263-72. PubMed ID: 17393458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
